Challenges in implementing the new lease accounting requirements
The Swiss biotech industry has reached record figures for 2017 in financing, infrastructure investment, and exports. This shows that confidence in its ability to create value and innovate remains unshaken. The report is published by the Swiss Biotech Association in collaboration with EY.
International mobility has become a crucial tax issue, as tax rates substantially differ between different countries and more and more highly paid workers migrate to countries, where the tax burden on high-income individuals is lower. This is especially true for professional athletes.
Our publication with relevant market data for Switzerland. This publication gives an overview of market multiples and cost of capital components per industry and includes also relevant macro-economic data used in business and other valuations such as impairment tests or purchase price allocations.
US tax reform is considerably impacting Swiss Groups with US subsidiaries. In Switzerland, import facilitations shall tackle the qualification as "island of high prices". Further, the new German government promises a number of changes in the tax agenda of its coalition agreement.
The nature of transactions has evolved, and yet the majority of them still underperform for the same reason: insufficient focus on human capital. Find out about EY's step change approach to transaction services that fully addresses people to maximise deal value.
How can investors focus beyond the short term returns?
Are you ready to take every step of the IPO journey?
Financial models are used in many firms to underpin management decisions with significant financial impact. However, such financial models do not always work as expected. Quite frequently they contain material errors. A funny cartoon and a high-impact example of such a spreadsheet error are highlighted here.
Anti-fine insurance or long term value creation?